BIOCRYST PHARMACEUTICALS INC ($BCRX)
Filing Information
| Accession Number | 0000882796-26-000015 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 18, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
450,000
Total Value
$2,199,000.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 150,000 | $5.51 | $826,500.00 | 550,703 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Mar 16, 2026 | Sale | 150,000 | $9.15 | $1,372,500.00 | 400,703 | Direct | โ | View Details | |
Chief Legal Officer | Emp. Stock Option (Right to Buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 150,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |